RBC Biotech Analyst Leo Timashev shares his take on the sector and discusses companies he covers that are in the news
- Mar 27
- 1 min read
He discusses Insmed, IDEAYA, Bicycle, Compass Pathways, Revolution Medicines, Cytokinetics, and CG Oncology
Chapters
General sentiment - 1:25
Insmed - 3:16
IDEAYA - 7:07
Bicycle - 9:44
Compass Pathways - 13:04
Revolution, Cytokinetics, CG - 16:03









.png)
